发明名称 RISPERIDONE SUSTAINED RELEASE MICROSPHERE COMPOSITION
摘要 A risperidone sustained release microsphere formulation is provided. The microsphere formulation includes risperidone or 9-hydroxy risperidone or salts thereof, and a polymer blend having a first uncapped lactide-glycolide copolymer and a second uncapped lactide-glycolide copolymer, in which the first uncapped lactide-glycolide copolymer is a copolymer with a high intrinsic viscosity and the second uncapped lactide-glycolide copolymer is a copolymer with a low intrinsic viscosity. The sustained release micro sphere formulation according to an embodiment of the present disclosure is suitable for large-scale industrialized production with improved stability, the in vivo release behavior of which will not change after long-term storage.
申请公布号 EP2701687(A1) 申请公布日期 2014.03.05
申请号 EP20120777430 申请日期 2012.04.10
申请人 SHANDONG LUYE PHARMACEUTICAL CO., LTD. 发明人 SUN, KAOXIANG;LIANG, RONGCAI;WANG, QILIN;WANG, WENYAN;LIU, WANHUI;LI, YOUXIN
分类号 A61K9/16;A61K9/14;A61K9/19;A61K31/519;A61K47/34;A61P25/18 主分类号 A61K9/16
代理机构 代理人
主权项
地址